ghk cu administration subcutaneous or topical GHK-Cu Before and After: Real Copper Peptide Results MIC+ Shot. | Elysian Size:500 Capsules - 1000mcg nasal spray

ghk cu administration subcutaneous or topical GHK-Cu Before and After: Real Copper Peptide Results MIC+ Shot. | Elysian Size:500 Capsules - 1000mcg nasal spray

MIC+ Shot. | Elysian Wellness Centre

J., Schuck, P

nasal spray

Size:500 Capsules - 1000mcg

Hypothetical Conservative Combination Protocol A conservative approach to combining these peptides would likely involve: Phase 1: Tirzepatide Establishment (Weeks 1-12) Week 1-4: Tirzepatide 2.5 mg weekly Week 5-8: Tirzepatide 5 mg weekly Week 9-12: Tirzepatide 7.5 mg weekly Cagrilintide: None (establish baseline tolerance) Phase 2: Cagrilintide Introduction (Weeks 13-20) Week 13-16: Tirzepatide 7.5 mg + Cagrilintide 0.6 mg weekly Week 17-20: Tirzepatide 7.5 mg + Cagrilintide 1.2 mg weekly Phase 3: Optimization (Week 21+) Tirzepatide 10-12.5 mg + Cagrilintide 2.4 mg weekly Adjust based on tolerance and response "The key principle when considering any peptide combination is sequential introduction with careful monitoring of tolerability markers, particularly gastrointestinal symptoms that could compound across mechanisms." This theoretical framework prioritizes safety through staged introduction, though actual clinical protocols would require medical supervision and monitoring